Learn about treatment results with TABRECTA
Understanding TABRECTA
TABRECTA® (capmatinib) tablets

What is TABRECTA? (ta brek’ tah)

-
TABRECTA is used to treat adults with NSCLC that:
-
has spread to other parts of the body (metastatic), and
-
whose tumors have an abnormality in their mesenchymal-epithelial transition (MET) gene. Your health care provider will perform a test to make sure that TABRECTA is right for you
It is not known if TABRECTA is safe and effective in children.

How does TABRECTA work?
-
TABRECTA works by blocking the activity of proteins made by MET exon 14 skipping that can cause your cancer to grow
-
TABRECTA affects both cancer cells and healthy cells
-
Although TABRECTA has been studied in people with NSCLC, how TABRECTA works has been demonstrated only in laboratory studies